How to Buy Carisma Therapeutics Stock

Carisma Therapeutics Inc

Carisma Therapeutics, Inc. , a biopharmaceutical company, develops chimeric antigen receptors (CAR) macrophages for the treatment of solid tumors.

Carisma Therapeutics stock last closed at $0.19, down 1.56% from the previous day, and has decreased 89.89% in one year. It has underperformed other stocks in the Biotechnology industry by 0.12 percentage points. Carisma Therapeutics stock is currently +18.13% from its 52-week low of $0.16, and -90.1% from its 52-week high of $1.91.

There are currently 41.79M CARM shares outstanding. The market cap of CARM is $7.90M. In the past 24 hours, 163,231 CARM shares were traded.

How to Buy Carisma Therapeutics Stock

Not sure how to invest in Carisma Therapeutics stock? Here's how.

  1. Choose where to buy Carisma Therapeutics stock: You need to pick a stock brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you figure out where to buy Carisma Therapeutics stock.
  2. Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
  3. Put funds into your brokerage account: Select your payment method and add your info.
  4. Research Carisma Therapeutics stock: The Carisma Therapeutics ticker symbol is CARM. Is Carisma Therapeutics stock a good investment? Should you buy shares of CARM? How do CARM's underlying business fundamentals look? Do top analysts think Carisma Therapeutics is a good buy? Why has CARM's stock price moved recently? (Hint: Our stock research tools can help you evaluate if CARM is a good stock to buy).
  5. Place your CARM buy order: Decide if you will purchase CARM shares at the current market price or use a limit order to buy CARM stock at a particular price.
  6. Keep an eye on your investment in CARM: Create a watchlist to the latest updates on your investment in Carisma Therapeutics stock.

Step 1: Choose where to buy Carisma Therapeutics stock

You will need a brokerage account to access the NASDAQ market and buy CARM stock.

A brokerage account enables you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

We believe that eToro is the best online stock brokerage. Here's why:

  • Invest in stocks with 0% commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
  • Access to world financial markets: From Tech to Utilities, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
  • Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other financial assets: Such as ETFs and cryptocurrencies.

Get $10 towards your stock purchase by signing up for an account with eToro today. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open a brokerage account

Now that you've selected your brokerage, it's time to fill out some personal info so you are able to buy CARM today.

How to Start a New Investment Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Input your personal data to open a new brokerage account.
  1. Submit your application by pressing the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Put funds into your brokerage account

Now that you have filled out your info on stock market app, your next step is to transfer the money for your investment:

Check out the tutorial below if you need help transferring money into your new brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Carisma Therapeutics stock

After you have decided on the best place to buy Carisma Therapeutics stock, it's very important to evaluate their stock prior to buying, so you truly understand the risk and upside.

Carisma Therapeutics shares data

CARM Price
$0.19
1w %
-11.27%
1y %
-89.89%
5y %
-98.19%
P/E
-0.13x
P/B
-0.28x
P/S
0.4x
PEG
N/A
Revenue
$19.63M
Earnings
-$60.48M
Fore. Rev. Growth
75.28%
Fore. Earn. Growth
N/A
Market Cap
$7.90M
Next Earnings
May 7, 2025
Next Dividend
N/A

CARM Due Diligence Score

WallStreetZen was designed to help average investors do more in-depth fundamental analysis in less time.

You can see all of the due diligence checks on CARM's stock page.

Is CARM stock overvalued?

Investors use many financial metrics, analyses, models, and charts to gauge CARM's intrinsic value.

You can do more valuation analysis on CARM's stock here.

Is CARM a healthy company?

Passed Financial Due Diligence Checks:

  • There are more short-term assets than short-term liabilities on the CARM balance sheet.

Failed Financial Due Diligence Checks:

  • There are more long-term liabilities than short-term assets on the CARM balance sheet.
  • CARM debt to equity ratio of -2.09 is negative.
  • CARM has $17.91M in cash and short term investments. This is not enough to cover its annual cash burn of $60.04M.
  • CARM profit margin has gone up by 2.74 percentage points in the past year, but the company is still unprofitable.
  • CARM has cash burn of 60040000. It does not have enough cash and short-term investments to cover this.
  • Total CARM debt is still negative.

Is it a good time to buy CARM stock, according to analysts?

Out of 4 Wall Street analysts who give recommendations on CARM, the consensus analyst rating on CARM is a Buy

It's important to note that analyst ratings are not stock recommendations, nor are they financial advice.

You can dig deeper into what analysts are projecting on the Carisma Therapeutics stock forecast page.

CARM Technical Indicators

SMA10
0.2
SMA20
0.25
SMA50
0.36
SMA100
0.45
SMA200
0.74
MACD
-0.05
MACD Signal
-0.06
MACD Histogram
0
RSI
27.93
Stochastic %K
17.68
Stochastic %D
17.26
StochRSI %K
76.9
StochRSI %D
67.42

CARM Performance Metrics

Last year, CARM revenue was $19.63M. During the last four year, CARM's revenue has increased by 14.97% per year. This was slower than the Biotechnology industry average of 44.31%.

You can analyze CARM's earnings and revenue performance here.

Latest Insiders Trades at CARM

Over the past year, executives and large shareholders at CARM have not bought or sold any shares.

Get more info about who owns CARM shares here.

Can I rely on CARM as an income stream?

No, Carisma Therapeutics doesn't provide an income stream by paying out dividends.

What do other investors have to say about CARM?

One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to find out what other community members have to say.

Step 5: Place your CARM buy order

You have two main types of orders:

  • Market order: A market order is an order to buy or sell a security at the best price on the market.
    Market orders are generally fine for most investors.
  • Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
    If you want to make sure you're buying or selling at a specific dollar amount limit, place a limit order.

Hit the Open button and your broker will place your order.

If you require additional info about investing in stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Keep an eye on your investment in CARM

Now that you own some CARM shares, you'll want to keep up with your new investment.

Start a watchlist to get the latest updates about your CARM stock.

CARM Feed

How to Buy Stock in Carisma Therapeutics

To summarize, here are the 6 steps to buy Carisma Therapeutics stock:

  1. Choose where to buy Carisma Therapeutics stock
  2. Open a brokerage account
  3. Put funds into your brokerage account
  4. Research Carisma Therapeutics stock
  5. Place your CARM buy order
  6. Keep an eye on your investment in CARM

If you are looking for a place to buy stocks, eToro is our recommended venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to watch your investment in Carisma Therapeutics, click the button below.

NASDAQ: CARM
$0.19-0.00 (-1.56%)
Updated Apr 21, 2025
Open eToro Account
Your capital is at risk.
NASDAQ: CARM
$0.19-0.00 (-1.56%)
Updated Apr 21, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Carisma Therapeutics share?

As of Apr 21, 2025, it costs $0.19 to buy one share of Carisma Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.09, you can buy 0.5 shares of CARM.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Carisma Therapeutics stock?

According to 4 Wall Street analysts who monitor Carisma Therapeutics, their consensus recommendation is to buy Carisma Therapeutics stock.

What is the best way to buy Carisma Therapeutics stock?

One way to place an order for Carisma Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.